Trending...
- KDM Engineering Wins the 2022 Business Diversity Award from the Edison Electric Institute
- Do You Have Any Experience With Play-To-Earn Games/NFTs?
- Andrew Eshelman Joins Board of Directors of Paxton Patterson
CHICAGO, Jan. 26, 2022 /PRNewswire/ -- According to the new market research report "Vaccines Market by Technology (Recombinant, Toxoid, Conjugate, RNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Influenza, DTP, HPV, MMR, COVID-19), Route of Administration (IM, SC, Oral), End user (Pediatric, Adult) - Global Forecast to 2026", published by MarketsandMarkets™, the global Vaccines Market (including COVID-19 vaccines) is projected to reach USD 149.2 billion by 2026 from USD 139.4 billion in 2021 during the forecast period. The global vaccines market (excluding COVID-19 vaccines) is projected to reach USD 67.2 billion by 2026 from USD 41.4 billion in 2021, at a CAGR of 10.2% from 2021 to 2026.
Browse in-depth TOC on "Vaccines Market"
254 – Tables
46 – Figures
302 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1155
The market growth is largely driven by the rise of emerging and re-emerging infectious diseases, increasing company initiatives to enhance vaccine R&D, growing government support for vaccine development, and the rising focus on immunization. However, the huge capital investments required for developing vaccines and low purchasing power in developing countries may restrain the market growth.
Conjugate vaccines segment accounted for the largest share of the technology segment (excluding COVID 19 vaccines)
Based on technology, the vaccines market (excluding COVID 19 vaccines) has been segmented into conjugate vaccines, recombinant vaccines, inactivated & subunit vaccines, live attenuated vaccines, toxoid vaccines, and viral vector vaccines. The conjugate vaccines segment accounted for the largest share of the global market (excluding COVID-19 vaccines), by technology, in 2020. The large share of this segment can be attributed to the increasing government support and rising company investments in conjugate vaccine development.
The Pneumococcal disease segment accounted for the largest share in 2020
Based on disease indication, the vaccines market is segmented into pneumococcal disease, influenza, combination vaccines, HPV, meningococcal disease, herpes zoster, rotavirus, MMR, varicella, hepatitis, DTP, polio, COVID-19, and other disease indications. The pneumococcal disease segment accounted for the largest share of the market, by disease indication, in 2020. The large share of this segment is attributed to the high incidence of pneumococcal disease and increasing government investments in pneumococcal vaccination programs.
More on illi News
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1155
Monovalent vaccines segment accounted for the largest share of the type segment
Based on type, the global vaccines market is segmented into monovalent and multivalent vaccines. The monovalent vaccines segment accounted for the largest share of the global market (excluding COVID-19 vaccines) in 2020. Growing disease prevalence has prompted initiatives for immunization against specific infectious diseases such as COVID 19. This has led to large market share for monovalent vaccines. Rising prevalence of emerging and re-emerging infectious diseases and R&D initiatives will contrive to drive the market for monovalent vaccines.
Pediatric vaccines segment accounted for the largest share of the end user segment
Based on end user, the global vaccines market is segmented into pediatric and adult users. In 2020, the pediatric users segment accounted for the largest share of the market (excluding COVID 19 vaccines), while the adult user segment is estimated to register the highest CAGR during the forecast period. Increased initiatives from government and non-government organizations and increasing company initiatives to develop advanced pediatric vaccines for preventing diseases are expected to drive market growth for pediatric vaccines.
Intramuscular & Subcutaneous route of administration segment accounted for the largest share of the route of administration segment
Based on the route of administration, the vaccines market is segmented into intramuscular and subcutaneous administration, oral administration, and other routes of administration. In 2020, the intramuscular and subcutaneous administration segment accounted for the largest share of the market (excluding COVID-19 vaccines). Intramuscular & Subcutaneous is one of the most prevalent route of administration for vaccines due to its precise control of dose and administration rate, rapid exposure to antigen, and ease of administration.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1155
Asia Pacific: The fastest-growing region in the vaccines market
Based on the region, the market is broadly segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. A growing number of drug and vaccine manufacturers are outsourcing large parts of R&D mostly to clinical/contract research and manufacturing organizations with the aim to reduce costs. The Asia Pacific has become the hub for global outsourced research and manufacturing organizations. Additionally, the increasing disposable income in emerging Asian countries is positively impacting the growth of the market.
More on illi News
Key players operating in the global vaccines market include GlaxoSmithKline Plc (UK), Merck & Co., Inc. (US), Sanofi SA (France), and Pfizer, Inc. (US).
Browse Adjacent Markets: Pharmaceuticals Market Research Reports & Consulting
Browse Related Reports:
Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html
Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, ELISA Analyzer, Luminometer), Service), Allergen (Food, Inhaled, Drug), Test Type (In Vivo, In Vitro), End User (Diagnostic Laboratories) - Global Forecast to 2026
https://www.marketsandmarkets.com/Market-Reports/allergy-diagnostics-market-232871701.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/vaccine-technologies-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/vaccine-technologies.asp
SOURCE MarketsandMarkets
Browse in-depth TOC on "Vaccines Market"
254 – Tables
46 – Figures
302 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1155
The market growth is largely driven by the rise of emerging and re-emerging infectious diseases, increasing company initiatives to enhance vaccine R&D, growing government support for vaccine development, and the rising focus on immunization. However, the huge capital investments required for developing vaccines and low purchasing power in developing countries may restrain the market growth.
Conjugate vaccines segment accounted for the largest share of the technology segment (excluding COVID 19 vaccines)
Based on technology, the vaccines market (excluding COVID 19 vaccines) has been segmented into conjugate vaccines, recombinant vaccines, inactivated & subunit vaccines, live attenuated vaccines, toxoid vaccines, and viral vector vaccines. The conjugate vaccines segment accounted for the largest share of the global market (excluding COVID-19 vaccines), by technology, in 2020. The large share of this segment can be attributed to the increasing government support and rising company investments in conjugate vaccine development.
The Pneumococcal disease segment accounted for the largest share in 2020
Based on disease indication, the vaccines market is segmented into pneumococcal disease, influenza, combination vaccines, HPV, meningococcal disease, herpes zoster, rotavirus, MMR, varicella, hepatitis, DTP, polio, COVID-19, and other disease indications. The pneumococcal disease segment accounted for the largest share of the market, by disease indication, in 2020. The large share of this segment is attributed to the high incidence of pneumococcal disease and increasing government investments in pneumococcal vaccination programs.
More on illi News
- Latino Leaders Network to Honor Mayor Tim Keller of Albuquerque with Antonio Villaraigosa Leadership Award at the 36th Tribute to Mayors
- Chamberlain University Receives Major Grant from American Nurses Foundation for Practice-Ready, Specialty-Focused™ Program
- Meet the owner of the tech company disrupting an $11.0bn industry
- Procurement Partners Welcomes Troy Thibodeau as Chief Marketing Officer
- Net Diatom diversifies with corporate restructure
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1155
Monovalent vaccines segment accounted for the largest share of the type segment
Based on type, the global vaccines market is segmented into monovalent and multivalent vaccines. The monovalent vaccines segment accounted for the largest share of the global market (excluding COVID-19 vaccines) in 2020. Growing disease prevalence has prompted initiatives for immunization against specific infectious diseases such as COVID 19. This has led to large market share for monovalent vaccines. Rising prevalence of emerging and re-emerging infectious diseases and R&D initiatives will contrive to drive the market for monovalent vaccines.
Pediatric vaccines segment accounted for the largest share of the end user segment
Based on end user, the global vaccines market is segmented into pediatric and adult users. In 2020, the pediatric users segment accounted for the largest share of the market (excluding COVID 19 vaccines), while the adult user segment is estimated to register the highest CAGR during the forecast period. Increased initiatives from government and non-government organizations and increasing company initiatives to develop advanced pediatric vaccines for preventing diseases are expected to drive market growth for pediatric vaccines.
Intramuscular & Subcutaneous route of administration segment accounted for the largest share of the route of administration segment
Based on the route of administration, the vaccines market is segmented into intramuscular and subcutaneous administration, oral administration, and other routes of administration. In 2020, the intramuscular and subcutaneous administration segment accounted for the largest share of the market (excluding COVID-19 vaccines). Intramuscular & Subcutaneous is one of the most prevalent route of administration for vaccines due to its precise control of dose and administration rate, rapid exposure to antigen, and ease of administration.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1155
Asia Pacific: The fastest-growing region in the vaccines market
Based on the region, the market is broadly segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. A growing number of drug and vaccine manufacturers are outsourcing large parts of R&D mostly to clinical/contract research and manufacturing organizations with the aim to reduce costs. The Asia Pacific has become the hub for global outsourced research and manufacturing organizations. Additionally, the increasing disposable income in emerging Asian countries is positively impacting the growth of the market.
More on illi News
- Chicago Resilient Communities Pilot Receives Over 176,000 Applications; Participant Selection Starts This Month
- Industrial and systems engineers honored at international conference
- Sims Tillirson VP, Business Development at PERKS appears on The Zemar Podcast
- Heather Morgan Joins Hilco Corporate Finance as Director of Capital Solutions
- Chicago: New 'Corridor Ambassador' Program to Support 13 Neighborhood Shopping Areas
Key players operating in the global vaccines market include GlaxoSmithKline Plc (UK), Merck & Co., Inc. (US), Sanofi SA (France), and Pfizer, Inc. (US).
Browse Adjacent Markets: Pharmaceuticals Market Research Reports & Consulting
Browse Related Reports:
Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html
Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, ELISA Analyzer, Luminometer), Service), Allergen (Food, Inhaled, Drug), Test Type (In Vivo, In Vitro), End User (Diagnostic Laboratories) - Global Forecast to 2026
https://www.marketsandmarkets.com/Market-Reports/allergy-diagnostics-market-232871701.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/vaccine-technologies-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/vaccine-technologies.asp
SOURCE MarketsandMarkets
Filed Under: Business
0 Comments
Latest on illi News
- Inventhelp Inventor Develops a Specialty Device Used to Prevent the Spread of Illness (CHK-147)
- Howie Mandel Joins NOCD to Change the OCD Conversation
- Average American Spends $78 On Jewelry Annually, Finds New CWC Jewelry Market Study
- OBL Crowns Chicago Regional Champion at Hope Academy Athletic Center and Awards $10,000 First Prize
- CARS.COM REPORTS 82% OF HOLIDAY TRAVELERS WILL ROAD-TRIP THIS MEMORIAL DAY, WITH MORE THAN HALF CARPOOLING TO SAVE ON GAS
- Hyfé Foods Turns Wasted Sugar Water into Flour Amidst a Supply Chain Crunch
- Midea Showcases FlashChef™ and Scan&Go™ Series for Professional Kitchens at the National Restaurant Association Show 2022
- Do You Have Any Experience With Play-To-Earn Games/NFTs?
- ForeFront Power Installs 2.4 MW of Solar at Eight of Anheuser-Busch's Partner Craft Breweries Across the Country
- Chicago: Statement from Mayor Lori E. Lightfoot
- 750 Prebuilt Assessments Now Available in Otus
- Chicago: Mayor Lightfoot and Alderman Ramirez-Rosa Join Bickerdike Redevelopment Corporation for the Grand Opening of Emmett Street Apartments
- Welcome AWATFIT The Fitness Truck to Fort Lauderdale
- Brazilian Plant-Based Food Innovator Future Farm To Participate in National Restaurant Association Show
- Walgreens Honors Veterans, Active Duty Military and Their Families with Weekend Discount in Honor of Memorial Day Friday, May 27 through Monday, May 30
- Cornerstone and Swiftlane Announce Strategic Technology Initiative to Create Safer Rental Communities in Denver
- KDM Engineering Wins the 2022 Business Diversity Award from the Edison Electric Institute
- Atkore Inc. Announces Acquisition of Talon Products, LLC
- TOKYO SKYTREE Celebrates Its 10th anniversary! Let's Pay Homage to this Japanese Landmark and World's Tallest Freestanding Broadcast Tower
- Andrew Eshelman Joins Board of Directors of Paxton Patterson